Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

U.S. Insurers Flag ‘U.S. Economic Recession’ as Top Investment Risk This Year

Daniel Kim Views  

▲ 미국 뉴욕 증권거래소 전광판에 떠 있는 골드먼 삭스 금융회사의 로고. 사진=뉴시스
Photo=Newsis

Major U.S. insurers ‘ top investment and finance executives have pinpointed ‘U.S. economic slowdown and recession’ as a macroeconomic risk that could impact investment portfolios this year.

Goldman Sachs Asset Management disclosed the results of a survey conducted among 359 Chief Investment Officers (CIOs) and Chief Financial Officers (CFOs) of U.S. insurance companies on the 3rd.

Of the respondents surveyed from January 17th to February 9th, 52% identified ‘U.S. economic slowdown and recession’ as the primary risk for this year, marking the highest percentage, including multiple responses.

Following closely was ‘credit and stock market volatility’ at 48%, with 46% of respondents citing ‘geopolitical tension.’ The responses also indicated concerns about ‘inflation’ (42%) and ‘monetary tightening’ (27%).

However, ‘China’s economic slowdown and recession’ appeared relatively low, with only 7% of all respondents expressing concern.

Additionally, 83% of respondents predicted that by the end of the year, the U.S. 10-year Treasury yield would reach the level of 3.90% to 4.10%, which was the rate at the time of the survey.

Among the respondents, 53% identified ‘private credit’ as the investment asset expected to yield high returns over the next year. This was followed by U.S. stocks (46%), government and public institution bonds (34%), investment-grade private company bonds (33%), developed market investment-grade corporate bonds (31%), and private funds (31%).

Alexandra Wilson-Elizondo, co-CIO of the Multi-Asset Solutions division at Goldman Sachs Asset Management, mentioned, “We anticipate central banks to gradually adopt a monetary easing strategy in the second half of the year,” adding, “We believe such a strategy will favor risk assets across bonds and stocks.”

She further commented, “However, considering the expansion of macroeconomic risks and the upcoming U.S. presidential election, there is a possibility of increased volatility and significant deviations in year-end returns.”

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LATEST] Latest Stories

  • BMW's Next-Gen EV: The Bold New i3 Touring Concept Revealed
  • LEGO Technic Ferrari SF-24 F1 Car: A 1,361-Piece Tribute to Ferrari’s 2024 F1 Season
  • Hyundai’s Ioniq 6 Just Took the Top Spot in J.D. Power’s EV Ownership Study
  • Jeep’s Recon: The Next-Gen 600HP Electric SUV Ready to Tackle the Market
  • Tesla Issues Recall for 376,000 Vehicles Due to Steering Assist Malfunction
  • Ferrari Reveals 499P Livery and Driver Lineup for 2025 World Endurance Championship

You May Also Like

  • 1
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE 

  • 2
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE 

  • 3
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE 

  • 4
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE 

  • 5
    Trump’s Soda Button and 12-Can Habit: A Recipe for Trouble?

    LIFESTYLE 

Popular Now

  • 1
    New FDA-Approved Pill Targets Constant Hunger in Children with PWS

    LIFESTYLE&nbsp

  • 2
    Too Much Exercise Might Not Help You Live Longer, Says New Study

    LIFESTYLE&nbsp

  • 3
    Novo Nordisk Just Bought the Next Big Thing in Weight Loss

    LIFESTYLE&nbsp

  • 4
    Strawberries + Nuts, Salmon & More: The Best Pairings for Your Wellness

    LIFESTYLE&nbsp

  • 5
    Truth About Narcolepsy: Symptoms, Causes, and How to Manage It

    LIFESTYLE&nbsp

Must-Reads

  • 1
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE 

  • 2
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE 

  • 3
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE 

  • 4
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE 

  • 5
    Trump’s Soda Button and 12-Can Habit: A Recipe for Trouble?

    LIFESTYLE 

Popular Now

  • 1
    New FDA-Approved Pill Targets Constant Hunger in Children with PWS

    LIFESTYLE 

  • 2
    Too Much Exercise Might Not Help You Live Longer, Says New Study

    LIFESTYLE 

  • 3
    Novo Nordisk Just Bought the Next Big Thing in Weight Loss

    LIFESTYLE 

  • 4
    Strawberries + Nuts, Salmon & More: The Best Pairings for Your Wellness

    LIFESTYLE 

  • 5
    Truth About Narcolepsy: Symptoms, Causes, and How to Manage It

    LIFESTYLE